| Literature DB >> 26399192 |
Jerzy P Szaflarski1, Angel L Ball2, Jennifer Vannest3, Aimee R Dietz4, Jane B Allendorfer1, Amber N Martin1, Kimberly Hart5, Christopher J Lindsell5.
Abstract
BACKGROUND: To provide a preliminary estimate of efficacy of constraint-induced aphasia therapy (CIAT) when compared to no-intervention in patients with chronic (>1 year) post-stroke aphasia in order to plan an appropriately powered randomized controlled trial (RCT).Entities:
Mesh:
Year: 2015 PMID: 26399192 PMCID: PMC4588672 DOI: 10.12659/MSM.894291
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Diagram of the CIAT study and associated testing (LMCA – left middle cerebral artery; TT – Token Test; NAT – Neuropsychological aphasia testing; CIAT – constraint-induced aphasia treatment).
Demographic characteristics for CIAT intervention and no-treatment (observation) groups.
| Control group (n=10) | CIAT group (n=14) | P value | |
|---|---|---|---|
| Age (years) – mean (SD) | 51 (13) | 57 (11) | 0.195 |
| White – n (%) | 9 (90.0) | 10 (71.4) | 0.358 |
| Non-Hispanic – n (%) | 10 (100.0) | 14 (100.0) | – |
| Male – n (%) | 5 (50.0) | 9 (64.3) | 0.678 |
| Past medical history – n (%) | |||
| History of HTN | 3 (30.0) | 7 (50.0) | 0.421 |
| History of DM | 1 (10.0) | 3 (21.4) | 0.615 |
| History of high cholesterol | 4 (40.0) | 8 (57.1) | 0.680 |
| History of CAD | 0 (0.0) | 2 (14.3) | 0.493 |
| History of MI | 1 (10.0) | 1 (7.1) | 1.000 |
| Smoking | 4 (40.0) | 7 (50.0) | 0.697 |
| Alcohol abuse | 0 (0.0) | 2 (16.6) | 0.493 |
| Drug abuse | 0 (0.0) | 0 (0.0) | – |
| Prior stroke | 2 (20.0) | 3 (21.4) | 1.000 |
| Severity – n (%) | |||
| Mild aphasia | 2 (20.0) | 6 (42.9) | 0.291 |
| Moderate aphasia | 4 (40.0) | 2 (14.3) | |
| Severe aphasia | 4 (40.0) | 6 (42.9) | |
| Time since stroke (months) – median (IQR) | 30 (58) | 38 (59) | 0.725 |
HTN – hypertension; DM – diabetes mellitus; CAD – coronary artery disease; MI myocardial infarction.
Figure 2CONSORT Diagram.
Difference in NAT scores at 3 time points by treatment group.
| Control (n=10) | CIAT (n=14) | Diff. | 95% CI | P value | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Lower | Upper | |||
| Mini Cal: Baseline | 22 | 9 | 26 | 9 | 3.671 | −4.291 | 11.633 | 0.347 |
| Mini Cal: Twelve weeks | 23 | 7 | 31 | 7 | 7.427 | 1.352 | 13.502 | 0.019 |
| Semantic Fluency Test: Baseline | 12 | 9 | 19 | 15 | 6.892 | −4.034 | 17.818 | 0.204 |
| Semantic Fluency Test: Two weeks | 12 | 7 | 21 | 14 | 8.714 | −0.332 | 17.761 | 0.058 |
| Semantic Fluency Test: Twelve weeks | 13 | 9 | 19 | 12 | 6.117 | −3.266 | 15.499 | 0.189 |
| Complex Ideation: Baseline | 8 | 3 | 8 | 3 | 0.410 | −2.325 | 3.146 | 0.758 |
| Complex Ideation: Two weeks | 8 | 2 | 8 | 4 | −0.068 | −2.865 | 2.729 | 0.960 |
| Complex Ideation: Twelve weeks | 9 | 2 | 9 | 2 | −0.475 | −2.603 | 1.654 | 0.645 |
| Controlled Oral Word Association Test: Baseline | 5 | 3 | 9 | 10 | 4.231 | −1.690 | 10.151 | 0.148 |
| Controlled Oral Word Association Test: Two weeks | 5 | 3 | 8 | 7 | 3.186 | −1.601 | 7.973 | 0.181 |
| Controlled Oral Word Association Test: Twelve weeks | 5 | 4 | 10 | 8 | 4.367 | −1.155 | 9.888 | 0.113 |
| Peabody Picture Vocabulary Test III: Baseline | 90 | 9 | 90 | 16 | 0.587 | −12.342 | 13.515 | 0.925 |
| Peabody Picture Vocabulary Test III: Two weeks | 90 | 10 | 94 | 12 | 4.788 | −5.916 | 15.492 | 0.360 |
| Peabody Picture Vocabulary Test III: Twelve weeks | 90 | 8 | 96 | 12 | 6.182 | −3.796 | 16.160 | 0.209 |
| Boston Naming Test (BNT): Baseline | 31 | 20 | 32 | 21 | 0.957 | −17.363 | 19.278 | 0.914 |
| Boston Naming Test (BNT): Two weeks | 33 | 21 | 34 | 20 | 0.940 | −17.253 | 19.134 | 0.915 |
| Boston Naming Test (BNT): Twelve weeks | 35 | 19 | 37 | 21 | 1.525 | −17.273 | 20.324 | 0.867 |
Unadjusted p values are provided. To correct for multiple comparisons the critical p value should be set to 0.003 (0.05/17 tests). All reported scores for all measures are reported unadjusted.
Figure 3Stick plots for each aphasia test at each time point split by treatment group. Each line represents a single case.
Patient characteristics by responder.
| Non-Responder (n=19) | Responder (n=5) | P Value | |
|---|---|---|---|
| CIAT – n (%) | 10 (52.6) | 4 (80.0) | 0.358 |
| Age – mean (SD) | 54 (12) | 58 (11) | 0.547 |
| Caucasian – n (%) | 14 (73.7) | 5 (100.0) | 0.544 |
| Male – n (%) | 12 (63.2) | 2 (40.0) | 0.615 |
| Months since stroke – median (IQR) | 28 (62) | 41 (35) | 0.406 |
| Past medical history – n (%) | |||
| Hypertension | 10 (52.6) | 0 (0.0) | 0.053 |
| High cholesterol | 11 (57.9) | 1 (20.0) | 0.317 |
| Diabetes | 4 (21.1) | 0 (0.0) | 0.544 |
| MI | 2 (10.5) | 0 (0.0) | 1.000 |
| CAD | 2 (10.5) | 0 (0.0) | 1.000 |
| Non-smoker | 9 (47.4) | 4 (80.0) | 1.000 |
| Severe aphasia – n (%) | 6 (31.6) | 4 (80.0) | 0.122 |
| Motor impairment – n (%) | 5 (50.0) | 3 (100.0) | 0.231 |
CIAT group only.